Trizepatide

Tirzepatide

What is it? Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist. It works by mimicking two naturally occurring hormones involved in appetite regulation, insulin secretion, and blood sugar control. It is approved in Canada and other countries for specific indications, including type 2 diabetes, and in some jurisdictions for chronic weight management in eligible adults.

Potential Benefits

Supports significant weight loss by reducing appetite and increasing feelings of fullness

Helps improve blood sugar control in people with type 2 diabetes

May reduce food cravings and overall calorie intake

Slows stomach emptying, helping promote longer-lasting satiety

May improve metabolic health when combined with diet and exercise

Has been shown to improve several cardiometabolic risk factors, including blood sugar, body weight, and waist circumference

Typical Treatment Duration

Tirzepatide is generally intended for long-term use when prescribed for chronic weight management or diabetes.

Treatment typically starts at a low dose, with gradual dose increases every 4 weeks to improve tolerability until the target maintenance dose is reached.

The appropriate dose and duration should be determined by a healthcare professional based on individual response and treatment goals.

Storage

Before first use: Refrigerate (2–8°C). Do not freeze.

After first use: Follow the storage instructions provided with the specific product. Protect from excessive heat and light.